EU SANCO Commissioner designate will put patients and consumers first, but see Pharma competitive

19 January 2010

European Members of Parliament are in the process of grilling prospective European Commissioners on their priorities and competences, among whom was John Dalli, Commissioner-designate for Health and Consumer Policy (SANCO), who is now Minister for Social Policy in Malta, as revealed by Jose Manuel Barroso, President of the European Commission, last year (The Pharma Letter December 1, 2009).

In response to questioning, Mr Dalli: said that consumers and patients will be "the underlying theme of my work: patients first, consumers first," but stressed that this did "not exclude a strong commitment that the pharma industry remains competitive."

On consumer policy, he said he was in favor of clear, informative labeling to empower "well-informed" consumers "who can take educated decisions on the goods and services they consume". He also spoke about the need for a greater focus on prevention, forwarding the dossier on cross-border healthcare and working on issues like alcoholism, smoking and obesity.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical